NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA ...

Eamonn started playing rugby when he was six years old and now plays in the second and third team for Huel Tring Rugby.

Emma Evens, 34, from Essex, suffers from tonic clonic seizures, which cause her to stiffen and convulse and can happen at any moment ...

The Ottawa Hospital is creating a comprehensive Epilepsy Program — a one-stop shop that will be a change-maker for patients.

Following its successful US launch and FDA clearance, Empatica is proud to announce that EpiMonitor, its pioneering epilepsy ...

Empatica announced today that it received CE mark approval for its EpiMonitor epilepsy monitoring solution. EpiMonitor, a ...

Emma Evens, 34, has been battling severe epilepsy and "tonic clonic" seizures, which cause her body to stiffen and convulse, ...

NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met ...

Shares of NeuroPace sank after the company said the study of its RNS system for treating drug-resistant idiopathic generalized epilepsy missed a primary endpoint. The stock was down 37% at $11.15 in ...

NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study ...

Learn about absence seizures, their symptoms, causes, and treatment options. Identify early signs and understand how to ...

Doctors revealed the unidentified 8-year-old developed a fever and suffered multiple seizures just days after unknowingly ...